ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 23297 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 23297; 2) Community: the network communities that were significantly associated with the response to NSC 23297; 3) Molecule: the relationships between components within communities and NSC 23297; 4) MDR: the compounds that were significantly associated with the NSC 23297.

NSC Compound Enrichment Correlation
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0406225271888773 0.22632617
NSC 408400 Null 0.0406225271888773 0.40871746
NSC 607088 Null 0.0406225271888773 0.30921609
NSC 624358 Tricyclo[4.4.0.0(2,7)]decane-5-one, 4,4-dibromo-2-methyl- 0.0406225271888773 0.53429624
NSC 638034 Null 0.0406225271888773 0.18732591
NSC 638487 (Z) 4-Acetoxy-(3,4',5)-trimethoxystilbene 0.0406225271888773 0.17167382
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.0406225271888773 -0.11329964
NSC 648365 Insulin-Methotrexate conjugate 0.0406225271888773 0.38575442
NSC 652175 2-Pyrazolin-5-one, 1-[(2-hydroxyphenyl)carbonyl]- 3-methyl-4-[(4-nitrophenyl)methylene]- 0.0406225271888773 0.053682224
NSC 657751 Null 0.0406225271888773 0.28019629
Total:96  Current:80    [First] [Prev] [Next] [Last]